Alharatani R , Ververi A , Beleza-Meireles A , Ji W , Mis E , Patterson QT , Griffin JN , Bhujel N , Chang CA , Dixit A , Konstantino M , Healy C , Hannan S , Neo N , Cash A , Li D , Bhoj E , Zackai EH , Cleaver R , Baralle D , McEntagart M , Newbury-Ecob R , Scott R , Hurst JA , Au PYB , Hosey MT , Khokha M , Marciano DK , Lakhani SA , Liu KJ .

BB/R015953/1 Biotechnology and Biological Sciences Research Council , 099175/Z/12/Z Wellcome Trust , Medical Research Council , HICF-1009-003 Department of Health, British Heart Foundation , UL1 TR001863 NCATS NIH HHS , R01 DK099478 NIDDK NIH HHS

                DiGeorge syndrome
                cleft palate

           BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1
           VELOCARDIOFACIAL SYNDROME; VCFS
           CHARGE SYNDROME
           BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2

Xtr Wt + ctnnd1 CRISPR (Fig.7.C)
Xtr Wt + ctnnd1 CRISPR (Fig.7.C)
Xtr Wt + ctnnd1 CRISPR (Fig.7.D)
Xtr Wt + ctnnd1 CRISPR (Fig.7.D)
Xtr Wt + ctnnd1 CRISPR (Fig.7.E)
Xtr Wt + ctnnd1 CRISPR (Fig.7.E)
Xtr Wt + ctnnd1 CRISPR (Fig.8.A)
Xtr Wt + ctnnd1 CRISPR (Fig.8.A)
Xtr Wt + ctnnd1 CRISPR (Fig.8.B)

	Figure 1. Pedigrees and identification of CTNND1 variants. (A) Pedigrees of individuals with identified variants. Family identifications, in brackets [A-I], and patient identification numbers correlate with Table 1. Filled boxes indicate affected individuals demonstrating collective phenotypes described in our cohort. A blank box with a vertical black line indicates an asymptomatic carrier (clinically unaffected). A box with an oblique line indicates a deceased individual. Lightly shaded boxes indicate individuals affected with one or more of the conditions described. (B) Schematic representation of the human p120-catenin protein structure and its domains. The variants described in our cohort are shown above the protein with a dark gray arrow. The light gray arrow with the (p.Arg315Cys) variant indicates the other CTNND1 mutation found in Patient 3 which was inherited from the unaffected father [A]. Arrows in blue, pink and brown represent the variants and their locations reported in Ghoumid et al. (2), Kievit et al. (1) and Cox et al. (3), respectively.
	Figure 2. Clinical presentation of individuals with a CTNND1 mutation. Facial photos (frontal and profile) show craniofacial features of patients. Note the narrow up-slanting palpebral fissures in Patients 3, 4 and 7–13; the hooded eyelids in Patients 3, 4 and 8–13; telecanthus in Patients 3, 4 and 9–13; the high arched eyebrows in Patients 1, 2, 6–8 and 11–13 and the thin lateral eyebrows in Patients 1 and 5–11. Patients 1 and 4 had missing eyelashes medially from the inner canthus; Patients 1, 2, 5 and 7 have distichiasis (double row of lashes), and mild ectropion of the lower eyelids was seen in Patients 1, 5 and 6. As evident, no patient shows signs of hair sparsity. Most patients had wide nasal bridges with broad nasal tips, while Patients 1, 2, 8 and 11 were also diagnosed with congenital choanal atresia. Patients 1, 2, 7–9, 11 and 12 showed thin upper lips, and while mid-face hypoplasia was observed, Patients 1, 3, 8, 11 and 13 also had mandibular prognathism. Scars from cleft lip operations are seen in Patients 7 and 9–13. Patient 3 was born with a sub-mucous cleft palate, a bifid uvula and VPI.
	Figure 3. Dental manifestations and intra-oral phenotypes of patients with a CTNND1 mutation. (A–D) A high-arched palate was seen, shown are palates of Patients 1, 2, 3 and 8. (E, F) Abnormalities in the morphology of the dentition included: fissured incisors in patient 11 (E, black arrowheads) and rotation of the incisors from the normal alignment shown in the non-cleft Patient 1 (F, black arrowhead). (G, H) Hypodontia (tooth agenesis) was a common phenotype, indicated by the black asterisk. Black arrowheads indicate retained primary teeth. Patient 3 also has a diminutive upper left lateral incisor (G, yellow arrowhead) and wide inter-dental spacing (G′, white arrowheads). (I–L) Dental orthopantograms (OPGs); missing teeth are indicated by white asterisks; diminutive teeth by yellow, macrodont teeth by magenta and supernumerary teeth by blue arrowheads, respectively. (I) OPG of Patient 8 at age 11 shows eight missing permanent teeth (white asterisks) and shows the eruption of the second permanent molars (white arrowheads) in place of the missing first permanent molars. Also shown are diminutive upper right and left lateral incisors (peg-shaped) (yellow arrowheads) and a macrodont lower left second primary molar (magenta arrowhead). (J) OPG of Patient 11, at the age of 14, shows three missing permanent teeth (white asterisks), an ectopic maxillary left permanent canine and rotated maxillary centrals and left lateral incisors and dilacerated roots of the lower second permanent molars. (K) OPG of Patient 2, taken at 4 years, shows missing teeth including a missing lower left first permanent molar (white asterisks); a reported macrodont upper left primary canine (magenta arrowhead) with an underlying missing successor (white asterisk); a macrodont lower left second primary molar (magenta arrowhead) and a supernumerary tooth (blue arrowhead). (L) OPG for Patient 13, taken at 7.5 years, confirms the absence of the upper left permanent lateral incisor and possibly the lower second permanent premolars.
	Figure 4. P120-catenin is expressed during relevant stages of human embryonic development. CTNND1 mRNA in situ hybridization at human Carnegie stages 13 (CS13) (A–C) and 21 (D–G). (A) Right lateral view of a CS13 human embryo, CTNND1 mRNA is strongly expressed in the head in all three pharyngeal arches (PA1, PA2 and PA3) and limb buds. Expression is specifically strong around the nasal placode and the maxillary and mandibular prominences. (B) Left lateral view, P120 is strongly expressed in the developing heart, frontonasal process, the trigeminal ganglion and the tenth cranial nerve. (C) P120 is ubiquitously expressed in the developing brain region in the rhombomeres, the forebrain and midbrain. (D–G) Coronal section through the head of a CS21 human embryo through a mid-palatal plane. (D) Strong expression is seen in the intrinsic muscles of the tongue: the superior longitudinal (magenta arrowhead), the transversal muscles of the tongue (black arrowhead) and the extrinsic genioglossus muscle (blue arrowhead). (E) CTNND1 mRNA is strongly expressed in the epithelium of the developing tooth bud. (F) CTNND1 is expressed on the dorsal epithelium of the palatal shelf (arrowhead) and in the epithelium of the tongue. (G) Expression is seen in the cardiomyocytes of the ventricular wall and the interventricular septum and in the cells of the endocardium (arrowhead). Scale bars = 100 μm. Abbreviations: PA1, first pharyngeal arch; PA2, second pharyngeal arch; PA3, third pharyngeal arch; Tg, trigeminal ganglion; Mx, maxillary process; Md, mandibular process; CN X, tenth cranial nerve; ULB, upper limb bud; S, somites; LLB, lower limb bud; NP, nasal placode; H, heart, FNP, frontonasal process; Tb, mandibular tooth bud; PS, palatal shelf; T, tongue; IVS, interventricular septum; VW, ventricular wall.
	Figure 7. Ctnnd1 knockouts in Xenopus give rise to craniofacial and heart defects. (A) Embryos were injected at the one-cell stage with sgRNAs, sgRNA1 and sgRNA2 targeting exons 3 and 7, respectively. (B) Ventral view showing blastopores at stage 11. Embryos injected with sgRNA1 had delayed blastopore closure (bottom row) compared to un-injected controls (UIC) (top row). The bar chart shows quantitation. Scale bars = 100 μm. (C) Confocal sections through the apical surface of ectodermal cells at stage 11 of embryos injected with sgRNA1 (e–h) and UICs (a–d). (C) (a–d) p120-catenin (a, green) is expressed in puncta at the cell membranes. E-cadherin (b, red) is expressed more evenly through the cell membranes. Both are colocalized at the cell–cell interface (c, d). Endogenous levels of p120-catenin and E-cadherin are diminished at the cell–cell interface in the sgRNA1-injected embryos (e, f). Residual p120-catenin and E-cadherin are seen in a spot-like pattern, only at the tricellular junctions (e–h, white arrowheads). (D) p120-catenin depletion led to lethality in embryos by the neurula stage. (E) Stage 46 tadpoles. (E) (i, l) Lateral views show a flattened profile in p120 CRISPR tadpoles (l) compared with UICs (i). (E) (j, m) Frontal views showing a reduction in the size of mouth opening and a persistent cement gland (white arrowhead) in p120 CRISPR tadpoles (m) compared with UICs (j). (E) (k, n) Ventral views showing a reduction in the size of craniofacial cartilages, altered cardiac looping (black-dashed outline) and altered gut coiling (yellow arrowhead) in p120 CRISPR tadpoles (n) compared to UICs (k). Quantification of craniofacial defects in UIC and p120 depleted tadpoles. Scale bars = 100 μm. ****P < 0.0001; ***P < 0.001.
	Figure 8. Ctnnd1 knockouts in Xenopus give rise to altered morphogenesis of the muscles and heart. (A) Immunofluorescent staining for collagen 2 (col2, magenta), muscle/pax2 (white) and nuclei (DAPI, blue); (a, anterior; p, posterior; d, dorsal; v, ventral). (A) (a, e) A lateral view of col2-positive branchial cartilages in UIC (a) and p120 CRISPR mutant (e) reveals the hypoplasia of mutant cartilages; however, cell morphology appears normal in p120 CRISPR mutants (h) (d and h, white arrowheads). (A) (b, c, f and g) Pax2-expressing muscles revealed a defect in the fibril organization of the rectus abdominus muscle in the p120 CRISPR tadpoles (f, white arrowhead) compared with the UIC muscles (b, white arrowhead); note insets in (c, g). (B) Ventral views of hearts of stage 46 tadpoles. Immunofluorescent staining for p120-catenin (green), E-cadherin (red) and DNA (blue). (B) (i–m) Controls; (n–r) p120 CRISPR mutant tadpoles. Morphologic defects are evident in the size of the heart and directionality of the loops (compare control heart (i) to mutant heart (n), yellow-dashed outlines). (B) (k, p) p120-catenin is strongly expressed in the heart of UIC tadpoles (k) but is lost in p120 CRISPR tadpoles (p). (B) (l, q) Note the absence of E-cadherin in the control and mutant hearts. Scale bars = 100 μm.
	Figure 9. Model of CTNND1 function in systemic disease. (A) CTNND1 mutations are not only implicated in conditions that affect epithelial structures but also systemic conditions that originate from mesenchymal roles of p120-catenin. Structures in pink circles have been described in previous publications on CTNND1 (1,2); structures in blue circles have been implicated previously in CTNND1-related disorders (1,2) and in this study. Structures in yellow circles have been identified in this study. (B) BCD is primarily due to disturbances in E-cadherin/p120 interactions. The inclusion of other organ systems described here highlights the involvement of other known molecular functions of p120, such as its role in the WNT signalling pathway and its interactions with Rho-GTPases, demonstrating its mesenchymal roles in producing these systemic conditions.

Ababneh, Blepharo-cheilo-dontic (BCD) syndrome: expanding the phenotype, case report and review of literature. 2014, Pubmed

Ababneh, Blepharo-cheilo-dontic (BCD) syndrome: expanding the phenotype, case report and review of literature. 2014, Pubmed
Abe, Maxillary first molar agenesis and other dental anomalies. 2010, Pubmed
Aho, Specific sequences in p120ctn determine subcellular distribution of its multiple isoforms involved in cellular adhesion of normal and malignant epithelial cells. 2002, Pubmed
Anastasiadis, Inhibition of RhoA by p120 catenin. 2000, Pubmed
Bartlett, Targeted p120-catenin ablation disrupts dental enamel development. 2010, Pubmed
Belcaro, CTNND2 deletion and intellectual disability. 2015, Pubmed
Bhattacharya, CRISPR/Cas9: An inexpensive, efficient loss of function tool to screen human disease genes in Xenopus. 2015, Pubmed , Xenbase
Buckingham, Building the mammalian heart from two sources of myocardial cells. 2005, Pubmed
Butts, The facial phenotype of the velo-cardio-facial syndrome. 2009, Pubmed
Callahan, Axis inhibition protein 2 (AXIN2) polymorphisms and tooth agenesis. 2009, Pubmed
Cho, Kazrin, and its binding partners ARVCF- and delta-catenin, are required for Xenopus laevis craniofacial development. 2011, Pubmed , Xenbase
Ciesiolka, p120 catenin is required for morphogenetic movements involved in the formation of the eyes and the craniofacial skeleton in Xenopus. 2004, Pubmed , Xenbase
Corsten-Janssen, More Clinical Overlap between 22q11.2 Deletion Syndrome and CHARGE Syndrome than Often Anticipated. 2013, Pubmed
Cox, Mutations in the Epithelial Cadherin-p120-Catenin Complex Cause Mendelian Non-Syndromic Cleft Lip with or without Cleft Palate. 2018, Pubmed
Danielian, Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. 1998, Pubmed
Davis, Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. 2006, Pubmed
Davis, A core function for p120-catenin in cadherin turnover. 2003, Pubmed
Deciphering Developmental Disorders Study, Prevalence and architecture of de novo mutations in developmental disorders. 2017, Pubmed
Del Valle-Pérez, Wnt controls the transcriptional activity of Kaiso through CK1ε-dependent phosphorylation of p120-catenin. 2011, Pubmed
Elder, Evidence that the functional beta-actin gene is single copy in most mice and is associated with 5' sequences capable of conferring serum- and cycloheximide-dependent regulation. 1988, Pubmed
Eley, A novel source of arterial valve cells linked to bicuspid aortic valve without raphe in mice. 2018, Pubmed
Elia, p120 catenin regulates dendritic spine and synapse development through Rho-family GTPases and cadherins. 2006, Pubmed
Fokstuen, Laryngeal atresia type III (glottic web) with 22q11.2 microdeletion: report of three patients. 1997, Pubmed
Fukumoto, The regulatory or phosphorylation domain of p120 catenin controls E-cadherin dynamics at the plasma membrane. 2008, Pubmed
Geis, Expression of the Armadillo family member p120cas1B in Xenopus embryos affects head differentiation but not axis formation. 1998, Pubmed , Xenbase
Ghoumid, Blepharocheilodontic syndrome is a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1. 2017, Pubmed
Gil da Silva Lopes, Blepharocheilodontic (BCD) syndrome: expanding the phenotype? 2003, Pubmed
Goos, Identification of causative variants in TXNL4A in Burn-McKeown syndrome and isolated choanal atresia. 2017, Pubmed
Gu, Xenopus delta-catenin is essential in early embryogenesis and is functionally linked to cadherins and small GTPases. 2009, Pubmed , Xenbase
Hammond, Periderm: Life-cycle and function during orofacial and epidermal development. 2019, Pubmed
Hatzfeld, The p120 family of cell adhesion molecules. 2005, Pubmed
Hendley, p120 Catenin is required for normal tubulogenesis but not epithelial integrity in developing mouse pancreas. 2015, Pubmed
Hofmeister, CTNND2-a candidate gene for reading problems and mild intellectual disability. 2015, Pubmed
Hong, Phosphorylation and isoform use in p120-catenin during development and tumorigenesis. 2016, Pubmed
Ireton, A novel role for p120 catenin in E-cadherin function. 2002, Pubmed
Ishiyama, Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion. 2010, Pubmed
Keirsebilck, Molecular cloning of the human p120ctn catenin gene (CTNND1): expression of multiple alternatively spliced isoforms. 1998, Pubmed
Khokha, Techniques and probes for the study of Xenopus tropicalis development. 2002, Pubmed , Xenbase
Kievit, Variants in members of the cadherin-catenin complex, CDH1 and CTNND1, cause blepharocheilodontic syndrome. 2018, Pubmed
Kim, Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin. 2004, Pubmed , Xenbase
Kochilas, The role of neural crest during cardiac development in a mouse model of DiGeorge syndrome. 2002, Pubmed
Lammi, Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. 2004, Pubmed
Laurikkala, TNF signaling via the ligand-receptor pair ectodysplasin and edar controls the function of epithelial signaling centers and is regulated by Wnt and activin during tooth organogenesis. 2001, Pubmed
Lehman, p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma. 2015, Pubmed
Leopold, Laryngeal abnormalities are frequent in the 22q11 deletion syndrome. 2012, Pubmed
Lewandoski, Analysis of Fgf8 gene function in vertebrate development. 1997, Pubmed
Lewis, The widely used Wnt1-Cre transgene causes developmental phenotypes by ectopic activation of Wnt signaling. 2013, Pubmed
Liu, Wnt/beta-catenin signaling directs multiple stages of tooth morphogenesis. 2008, Pubmed
Lohi, Expression of Axin2 indicates a role for canonical Wnt signaling in development of the crown and root during pre- and postnatal tooth development. 2010, Pubmed
Lu, Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases. 2016, Pubmed
Lungova, β-Catenin signaling is essential for mammalian larynx recanalization and the establishment of vocal fold progenitor cells. 2018, Pubmed
Marciano, p120 catenin is required for normal renal tubulogenesis and glomerulogenesis. 2011, Pubmed
Mariner, EGFR signaling to p120-catenin through phosphorylation at Y228. 2004, Pubmed
Mariner, ARVCF localizes to the nucleus and adherens junction and is mutually exclusive with p120(ctn) in E-cadherin complexes. 2000, Pubmed
Medina, Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome. 2000, Pubmed
Miyamoto, Association of anterior glottic webs with velocardiofacial syndrome (chromosome 22q11.2 deletion). 2004, Pubmed
Montonen, Tissue distribution and cell type-specific expression of p120ctn isoforms. 2001, Pubmed
Mostowska, Nucleotide variants of genes encoding components of the Wnt signalling pathway and the risk of non-syndromic tooth agenesis. 2013, Pubmed
Mostowska, Axis inhibition protein 2 (AXIN2) polymorphisms may be a risk factor for selective tooth agenesis. 2006, Pubmed
Mues, The WNT10A gene in ectodermal dysplasias and selective tooth agenesis. 2014, Pubmed
Nishi, Exome sequencing-based identification of mutations in non-syndromic genes among individuals with apparently syndromic features. 2016, Pubmed
Nivard, Further confirmation of the association between anxiety and CTNND2: replication in humans. 2014, Pubmed
Oas, p120-Catenin is required for mouse vascular development. 2010, Pubmed
Park, Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. 2005, Pubmed , Xenbase
Park, Frodo links Dishevelled to the p120-catenin/Kaiso pathway: distinct catenin subfamilies promote Wnt signals. 2006, Pubmed , Xenbase
Paulson, Misexpression of the catenin p120(ctn)1A perturbs Xenopus gastrulation but does not elicit Wnt-directed axis specification. 1999, Pubmed , Xenbase
Perez-Moreno, p120-catenin mediates inflammatory responses in the skin. 2006, Pubmed
Peterson, Bicuspid aortic valve formation: Nos3 mutation leads to abnormal lineage patterning of neural crest cells and the second heart field. 2018, Pubmed
Reynolds, Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. 1994, Pubmed
Reynolds, The gene encoding p120cas, a novel catenin, localizes on human chromosome 11q11 (CTNND) and mouse chromosome 2 (Catns). 1996, Pubmed
Reynolds, Emerging roles for p120-catenin in cell adhesion and cancer. 2004, Pubmed
Rual, Human ORFeome version 1.1: a platform for reverse proteomics. 2004, Pubmed
Schackmann, p120-catenin in cancer - mechanisms, models and opportunities for intervention. 2013, Pubmed
Shawlot, Restricted beta-galactosidase expression of a hygromycin-lacZ gene targeted to the beta-actin locus and embryonic lethality of beta-actin mutant mice. 1998, Pubmed
Shprintzen, A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. 1978, Pubmed
Sirotkin, Identification of a new human catenin gene family member (ARVCF) from the region deleted in velo-cardio-facial syndrome. 1997, Pubmed
Smalley-Freed, p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice. 2010, Pubmed
Song, WNT10A variants are associated with non-syndromic tooth agenesis in the general population. 2014, Pubmed
Srivastava, Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. 1997, Pubmed
Stairs, Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. 2011, Pubmed
Sun, Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. 1998, Pubmed
Tabler, Cilia-mediated Hedgehog signaling controls form and function in the mammalian larynx. 2017, Pubmed
Turner, Loss of δ-catenin function in severe autism. 2015, Pubmed
Vinyoles, Multivesicular GSK3 sequestration upon Wnt signaling is controlled by p120-catenin/cadherin interaction with LRP5/6. 2014, Pubmed
Vissers, Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. 2004, Pubmed
Wang, Expression patterns of WNT/β-CATENIN signaling molecules during human tooth development. 2014, Pubmed
Wildenberg, p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho. 2006, Pubmed
Wilkinson, Expression of the proto-oncogene int-1 is restricted to specific neural cells in the developing mouse embryo. 1987, Pubmed
Wong, CHARGE syndrome: a review of the immunological aspects. 2015, Pubmed
Xia, Adhesion-associated and PKC-modulated changes in serine/threonine phosphorylation of p120-catenin. 2003, Pubmed
Yanagisawa, p120 catenin is essential for mesenchymal cadherin-mediated regulation of cell motility and invasiveness. 2006, Pubmed
van den Boogaard, Mutations in WNT10A are present in more than half of isolated hypodontia cases. 2012, Pubmed